AVRO Stock Surges on Upbeat Drug Data

Despite recent behavior on the charts, analysts are resoundingly bullish on the stock

Digital Content Manager
Jul 15, 2019 at 9:50 AM
facebook X logo linkedin


The shares of Avrobio Inc (NASDAQ:AVRO) are popping today after the drugmaker announced positive data from its clinical trials of its investigational gene therapy drug AVR-RD-01 in patients with Fabry Disease, as well as an 87% substrate reduction in its first post-treatment kidney biopsy. AVRO is up 7.1% at $15.29 in response.

Since spiking at $28.52 in early April, AVRO has suffered a gradual descent on the charts. While the $13 region has caught the stock on multiple occasions, pressure at its 50-day and 40-day moving averages just stifled its most recent rally attempt. Now, Avrobio is trading back north of its 40-day trendline, and is threatening to conquer its 50-day, too. 

Despite it's recent behavior, analysts have been incredibly optimistic on the security, with eight in coverage giving it a "buy" or better rating, and only one saying "hold." What's more, the consensus 12-month target price of $36.50 is at a 59.2% premium to last Friday's close, and represents an area AVRO hasn't reached in nearly two years. 

Shorts have started to rapidly unwind, too, down over 30% in the last two reporting periods to 670,705 shares -- the lowest volume since last February. These bearish bets cover only 2.9% of the stock's available float. However, it would take nearly a week to cover these pessimistic positions at AVRO's average pace of trading, which could mean there's potential for a short squeeze. 

 

 

Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on C3.ai calls
238.5% GAIN on Oracle calls

 
 
 


 
 

Rainmaker Ads CGI